Log in or Sign up for Free to view tailored content for your specialty!
Gynecologic Cancer News
FDA approves Jemperli for endometrial cancer subset
The FDA granted accelerated approval to dostarlimab-gxly for treatment of certain women with endometrial cancer.
Remote symptom monitoring can ‘close care gaps’ for people with cancer
Technology-enabled symptom monitoring in conjunction with nurse practitioner follow-up provided responsive care to patients with cancer during the COVID-19 pandemic, according to study results.
Log in or Sign up for Free to view tailored content for your specialty!
Women with ovarian cancer at higher risk for mental health disorders
Women with ovarian cancer appeared to be at greater risk for anxiety, depression and adjustment disorder within the first 2 years of diagnosis than women in the general population, study results showed.
FDA grants priority review to tisotumab vedotin for advanced cervical cancer
The FDA granted priority review to tisotumab vedotin for treatment of certain women with cervical cancer, according to the agent’s manufacturer.
Adolescents and young adults with cancer require dedicated services, research
Going through cancer during transitional adolescent and young adult years can present additional social, financial and mental health challenges that add to the stressors of diagnosis and treatment.
FDA clears IND application for immunotherapy combination to treat solid tumors
The FDA cleared an investigational new drug application for the combination of AFM24 and SNK-01 in patients with solid tumors that express epidermal growth factor receptor, according to a joint press release from each agent’s manufacturer.
Adjuvant therapy does not extend survival in high-risk endometrial cancer
Postoperative systemic or radiation therapy did not extend survival for women with high-risk stage I endometrial cancer, according to results presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Paclitaxel-cisplatin combination extends PFS in advanced epithelial ovarian cancer
The addition of paclitaxel to cisplatin in a hyperthermic intraperitoneal chemotherapy regimen doubled PFS among women with advanced epithelial ovarian cancer undergoing interval debulking surgery, study results showed.
Interventions overcome endometrial cancer clinical trial inequity in Deep South
Interventions designed to improve care for Black women with endometrial cancer can help overcome clinical trial inequities, according to findings presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Rucaparib significantly extends PFS in advanced, relapsed BRCA-mutated ovarian cancer
Rucaparib significantly prolonged PFS compared with chemotherapy for women with BRCA-mutated advanced, relapsed ovarian cancer, according to a study presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.